Posted on June 4, 20266/4/26
Winning in the EU JCA Era: Why Proactive Intelligence Will Define Market Access Success
Posted on May 29, 20265/29/26
U.S. Drug Pricing Is Entering a More Complex Phase
Posted on May 8, 20265/8/26
How MFN is Reshaping Global Drug Pricing – and How NAVLIN Insights Tracks It
Posted on April 10, 20264/10/26
Stay Ahead of Change with NAVLIN Daily’s Global Policy Watch
Posted on March 9, 20263/9/26
Key Implications of Recent U.S. PBM Reforms
Posted on January 14, 20261/14/26
NAVLIN Daily 2025 Round-Up: The Pricing and Policy Trends Redefining Market Access
Posted on December 10, 202512/10/25
Predicting PICOs for EU HTA: The Validated PICO Planner Approach Based on Retrospective Analysis
Posted on September 30, 20259/30/25
Strategic PICO Planning: Navigating Oncology Markets with NAVLIN by EVERSANA
Posted on September 30, 20259/30/25
Strategic PICO Planning: Enhancing Early-Phase Development for Market Access
Posted on September 11, 20259/11/25